ClinicalTrials.Veeva

Menu

Hidradenitis Suppurativa (HS) Tunneling Wounds

University of Miami logo

University of Miami

Status

Completed

Conditions

Hidradenitis Suppurativa

Treatments

Device: antibiofilm surfactant wound gel (ABWG)

Study type

Interventional

Funder types

Other

Identifiers

NCT04648631
20201035

Details and patient eligibility

About

The purpose of this study is to look at the change in the microbiome (bacterial composition) of an HS tunneling wound and examine if treatment with an antibiofilm surfactant wound gel (ABWG) (a topical medication that will fight bacteria attached to the surface of those tunnels) changes the bacterial composition of the wounds.

Enrollment

15 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Adults 18 years old and older
  2. Have diagnosis of HS confirmed by a dermatologist
  3. Have at least one HS related tunneling wound that is at least 2 centimeters in length
  4. Able to provide informed consent

Exclusion criteria

  1. Individuals who are not yet adults
  2. Women known to be pregnant
  3. Prisoners
  4. Subjects, who in the opinion of the PI, cannot comply with home application of the treatment.

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

15 participants in 1 patient group

ABWG
Experimental group
Description:
The participants in this group will be receiving the ABWG daily for 4 consecutive weeks.
Treatment:
Device: antibiofilm surfactant wound gel (ABWG)

Trial documents
1

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems